Wearable device-derived sleep metrics may help monitor inflammatory bowel disease activity and response to biologic therapy, ...

When comparing inflammatory bowel disease mortality from before the pandemic with during, the gap between related deaths ...

Patients with chronic conditions who are failing on conventional therapies may be suffering from undiagnosed major depression ...

Despite challenges for approval and access, regenerative therapies for retinal diseases may not be far away from becoming ...

In this video from the American Academy of Dermatology Annual Meeting, Brian S. Kim, MD, MTR, discusses the expansion of ...

Sharp differences in mortality rates and costs related to alcohol-associated hepatitis before and after the COVID-19 pandemic ...

CHICAGO — Alcohol-related cirrhosis carries a twofold higher mortality risk than cirrhosis stemming from metabolic ...

The 5th Circuit Court of Appeals has temporarily restored a rule the FDA lifted in 2023 that requires mifepristone to be ...

The AI-assisted colonoscopy era was associated with a 47% reduction in interval colorectal cancer incidence and higher ...

The FDA has approved the first proteolysis-targeting chimera for any oncologic indication. Vepdegestrant (Veppanu, Arvinas ...

AI highlighted evidence-based research when asked about the safety of acetaminophen use during pregnancy, according to data ...

Until biomarkers that can predict treatment response emerge, early and aggressive treatment is recommended in lupus nephritis ...